SPAN / Span-America Medical Systems, Inc. - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

SPAN / Span-America Medical Systems, Inc. / WELLS FARGO & COMPANY/MN Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2) SPAN AMER MED SYS INCCHG (Name of Issuer) Common Stocks (Title of Class of Securities) 846396109 (CUSIP Number) June 30, 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sc

Span-America Medical Systems 15-12G

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 0-11392 SPAN-AMERICA MEDICAL SYSTEMS, INC. (Exact name of registrant as spe

Span-America Medical Systems FORM S-8 POS

span20170616s8pos.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Post-Effective Amendment No. 1 to Form S-8, Registration Statement No. 333-146660 Post-Effective Amendment No. 1 to Form S-8, Registration Statement No. 333-75656 Post-Effective Amendment No. 2 to Form S-8, Registration Statement No. 333-70533 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 19

Span-America Medical Systems FORM S-8 POS

span20170616s8pos.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Post-Effective Amendment No. 1 to Form S-8, Registration Statement No. 333-146660 Post-Effective Amendment No. 1 to Form S-8, Registration Statement No. 333-75656 Post-Effective Amendment No. 2 to Form S-8, Registration Statement No. 333-70533 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 19

Span-America Medical Systems FORM S-8 POS

span20170616s8pos.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Post-Effective Amendment No. 1 to Form S-8, Registration Statement No. 333-146660 Post-Effective Amendment No. 1 to Form S-8, Registration Statement No. 333-75656 Post-Effective Amendment No. 2 to Form S-8, Registration Statement No. 333-70533 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 19

Changes in Control of Registrant, Material Modification to Rights of Security Holders, Unregistered Sales of Equity Securities, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets, 8-K

8-K 1 span201706168k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 16, 2017 SPAN-AMERICA MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) South Carolina 0-11392 57-0525804 (State or ot

Span-America Medical Systems SCHEDULE 14D9/A

span20170616sc14d9a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (Amendment No. 3) Solicitation/Recommendation Statement Under Section 14(d)(4) of the Securities Exchange Act of 1934 Span-America Medical Systems, Inc. (Name of Subject Company) Span-America Medical Systems, Inc. (Name of Person Filing statement) Common Stock, no par value (Title of Clas

Span-America Medical Systems SCHEDULE 14D9/A

span20170602sc14d9a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (Amendment No. 2) Solicitation/Recommendation Statement Under Section 14(d)(4) of the Securities Exchange Act of 1934 Span-America Medical Systems, Inc. (Name of Subject Company) Span-America Medical Systems, Inc. (Name of Person Filing statement) Common Stock, no par value (Title of Clas

Span-America Medical Systems SCHEDULE 14D9/A

span20170531sc14d9a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (Amendment No. 1) Solicitation/Recommendation Statement Under Section 14(d)(4) of the Securities Exchange Act of 1934 Span-America Medical Systems, Inc. (Name of Subject Company) Span-America Medical Systems, Inc. (Name of Person Filing statement) Common Stock, no par value (Title of Clas

Span-America Medical Systems SCHEDULE 14D9

span20170516b_sc14d9.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (Rule 14d-101) Solicitation/Recommendation Statement Under Section 14(d)(4) of the Securities Exchange Act of 1934 Span-America Medical Systems, Inc. (Name of Subject Company) Span-America Medical Systems, Inc. (Name of Person Filing statement) Common Stock, no par value (Title of Class

SPAN / Span-America Medical Systems, Inc. FORM 10-Q (Quarterly Report)

span2017040110q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q X QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended April 1, 2017 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From to Commission File Number 0-11392 SPAN-A

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 4, 2017 SPAN-AMERICA MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) South Carolina 0-11392 57-0525804 (State or other jurisdiction of incorporation) (

Span-America Reports Second Quarter Fiscal 2017 Results

Exhibit 99.1 Span-America Reports Second Quarter Fiscal 2017 Results GREENVILLE, S.C.-(BUSINESS WIRE)-May 4, 2017-Span-America Medical Systems, Inc. (NASDAQ:SPAN) today reported its results for the second fiscal quarter ended April 1, 2017. Net sales for the second quarter of fiscal 2017 were up 3% to $15.2 million compared with $14.9 million in the second quarter of fiscal 2016. Net income for th

Span-America Investor Call Script Tuesday, May 2 at 8:00 am ET

ex99-1.htm Exhibit 99.1 Span-America Investor Call Script Tuesday, May 2 at 8:00 am ET Richard Coggins Thank you, operator, and thank you, everyone, for participating in today's conference call to discuss the proposed transaction for Span-America Medical Systems, Inc. to be acquired by Savaria Corporation. First, I would like to note that Span-America will release our full second quarter fiscal 20

Span-America Medical Systems SCHEDULE 14D9C

span20170502sc14d9.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (RULE 14d-101) SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION 14(D)(4) OF THE SECURITIES EXCHANGE ACT OF 1934 Span-America Medical Systems, Inc. (Name of Subject Company) Span-America Medical Systems, Inc. (Name of Person Filing Statement) Common Stock, no par value per share (Title o

Span-America Medical Systems, Inc. Announces Preliminary Results for Second Quarter Declares Quarterly Cash Dividend of $0.16 Per Share

Exhibit 99.1 Span-America Medical Systems, Inc. Announces Preliminary Results for Second Quarter Declares Quarterly Cash Dividend of $0.16 Per Share GREENVILLE, S.C.-(BUSINESS WIRE)-May 1, 2017-Span-America Medical Systems, Inc. (?Span-America?) (NASDAQ: SPAN) announced today preliminary results for the second quarter ended April 1, 2017, that reflect growth in sales and net income since the prior

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 1, 2017 SPAN-AMERICA MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) South Carolina 0-11392 57-0525804 (State or other jurisdiction of incorporation) (

Employee FAQ

EX-99.3 4 ex99-3.htm EXHIBIT 99.3 Exhibit 99.3 Span-America Employee FAQ 1. What was announced today? ● The Span-America board of directors has approved the acquisition of Span-America by Savaria Corporation. 2. Who is Savaria? ● Savaria is a Canadian manufacturer of accessibility lifts, wheelchair-accessible vans and elevators. 3. Why is Span-America combining with Savaria? ● Span-America’s board

SPAN-AMERICA MEDICAL SYSTEMS, INC. AGREES TO BE ACQUIRED BY SAVARIA CORPORATION All-Cash Tender Offer of $29 Per Share

EX-99.1 2 ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Contact: Jim Ferguson President and Chief Executive Officer (864) 288-8877, ext. 6912 SPAN-AMERICA MEDICAL SYSTEMS, INC. AGREES TO BE ACQUIRED BY SAVARIA CORPORATION - All-Cash Tender Offer of $29 Per Share Greenville, South Carolina – May 1, 2017 –Span-America Medical Systems, Inc. (“Span-America”) (NASDAQ: SPAN) announced today that it has reached a

Dear Valued Supplier,

EX-99.4 5 ex99-4.htm EXHIBIT 99.4 Exhibit 99.4 Dear Valued Supplier, The Span-America board of directors has approved the acquisition of Span-America by Savaria Corporation, a dynamic, industry-leader in the manufacture and sale of accessibility lifts, wheelchair-accessible vans and elevators. Span-America’s news release announcing the transaction is attached. We expect the transaction to close by

Span-America Medical Systems SCHEDULE 14D9

span20170430sc14d9.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (RULE 14d-101) SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION 14(D)(4) OF THE SECURITIES EXCHANGE ACT OF 1934 Span-America Medical Systems, Inc. (Name of Subject Company) Span-America Medical Systems, Inc. (Name of Person Filing Statement) Common Stock, no par value per share (Title o

What was announced today?

ex99-7.htm Exhibit 99.7 Span-America Customer FAQ 1. What was announced today? ● The Span-America board of directors has approved the acquisition of Span-America by Savaria Corporation. 2. Who is Savaria? ● Savaria is a Canadian manufacturer of accessibility lifts, wheelchair-accessible vans and elevators. 3. Why is Span-America combining with Savaria? ● Span-America’s board of directors believes

Span-America Supplier/Vendor FAQ

EX-99.5 6 ex99-5.htm EXHIBIT 99.5 Exhibit 99.5 Span-America Supplier/Vendor FAQ 1. What was announced today? ● The Span-America board of directors has approved the acquisition of Span-America by Savaria Corporation. 2. Who is Savaria? ● Savaria is a Canadian manufacturer of accessibility lifts, wheelchair-accessible vans and elevators. 3. Why is Span-America combining with Savaria? ● Span-America’

Dear Span-America Team Members:

ex99-2.htm Exhibit 99.2 Dear Span-America Team Members: The Span-America board of directors has approved an agreement to sell Span-America Medical Systems, Inc. to Savaria Corporation. Under the terms of the agreement, Savaria Corporation is purchasing all of Span-America?s outstanding shares for $29.00 per share. The transaction, which was unanimously approved by Span-America?s board of directors

Dear Valued Customer,

ex99-6.htm Exhibit 99.6 Dear Valued Customer, The Span-America board of directors has approved the acquisition of Span-America by Savaria Corporation, a dynamic, industry-leader in the manufacture and sale of accessibility lifts, wheelchair-accessible vans and elevators. Span-America’s news release announcing the transaction is attached. We expect the transaction to close by the end of June 2017.

STOCK OPTION CANCELLATION AGREEMENT

ex10-2.htm Exhibit 10.2 STOCK OPTION CANCELLATION AGREEMENT This STOCK OPTION CANCELLATION AGREEMENT (this ?Agreement?) is made and entered into as of May 1, 2017, by and between the undersigned individual optionee (the ?Optionee?) and Span-America Medical Systems, Inc., a South Carolina corporation (the ?Company?). Recitals A. The Company has granted the Optionee the option to purchase shares in

AGREEMENT AND PLAN OF MERGER SAVARIA CORPORATION, SAVARIA (SC) INC. SPAN-AMERICA MEDICAL SYSTEMS, INC. Dated as of May 1, 2017 TABLE OF CONTENTS

ex2-1.htm Exhibit 2.1 AGREEMENT AND PLAN OF MERGER among SAVARIA CORPORATION, SAVARIA (SC) INC. and SPAN-AMERICA MEDICAL SYSTEMS, INC. Dated as of May 1, 2017 TABLE OF CONTENTS Page Article I THE OFFER 2 Section 1.1 The Offer 2 Section 1.2 Company Actions 5 Section 1.3 Directors 6 Section 1.4 Top-Up Option 7 Article II THE MERGER 8 Section 2.1 The Merger 8 Section 2.2 Closing 8 Section 2.3 Effecti

SPAN-AMERICA MEDICAL SYSTEMS, INC. RESOLUTIONS OF THE BOARD OF DIRECTORS AMENDING THE AMENDED & RESTATED BYLAWS May 1, 2017

ex3-1.htm Exhibit 3.1 SPAN-AMERICA MEDICAL SYSTEMS, INC. RESOLUTIONS OF THE BOARD OF DIRECTORS AMENDING THE AMENDED & RESTATED BYLAWS May 1, 2017 The board of directors (the ?Board?) of Span-America Medical Systems, Inc., a South Carolina corporation (the ?Company?) hereby adopts the following resolutions at a meeting duly called and held on the date set forth above: WHEREAS, the Board has determi

SPAN-AMERICA MEDICAL SYSTEMS, INC. AGREES TO BE ACQUIRED BY SAVARIA CORPORATION All-Cash Tender Offer of $29 Per Share

ex99-1.htm Exhibit 99.1 Contact: Jim Ferguson President and Chief Executive Officer (864) 288-8877, ext. 6912 SPAN-AMERICA MEDICAL SYSTEMS, INC. AGREES TO BE ACQUIRED BY SAVARIA CORPORATION - All-Cash Tender Offer of $29 Per Share Greenville, South Carolina ? May 1, 2017 ?Span-America Medical Systems, Inc. (?Span-America?) (NASDAQ: SPAN) announced today that it has reached an agreement to be acqui

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities

span201704298k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 1, 2017 SPAN-AMERICA MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) South Carolina 0-11392 57-0525804 (State or other jurisdiction

FORM OF

ex10-1.htm Exhibit 10.1 FORM OF TENDER SUPPORT AGREEMENT A Tender Support Agreement in this form has been entered into by and among Savaria Corporation, Savaria (SC) Inc. and each Stockholder listed on Schedule A hereto. Schedule A to this form of agreement sets forth the share ownership of all of the Stockholders to such agreements; however, each Stockholder?s individual Tender Support Agreement

Span-America Medical Systems ESP

span20170307corresp.htm March 10, 2017 VIA EMAIL and FEDEX Ms. Kate Tillan Mr. Martin James Division of Corporation Finance U.S. Securities and Exchange Commission Mail Stop 3030 100 F Street, NE Washington, D.C. 20549 Re: Span-America Medical Systems, Inc. Form 10-K for the Fiscal Year Ended October 1, 2016 Filed December 23, 2016 File No. 000-11392 Dear Ms. Tillan and Mr. James: Thank you for yo

Submission of Matters to a Vote of Security Holders

8-K 1 span201702268k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 22, 2017 SPAN-AMERICA MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) South Carolina 0-11392 57-0525804 (State o

Span-America Medical Systems FORM 10-Q (Quarterly Report)

span2016123110q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q X QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended December 31, 2016 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From to Commission File Number 0-11392 SP

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 2, 2017 SPAN-AMERICA MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) South Carolina 0-11392 57-0525804 (State or other jurisdiction of incorporati

Span-America Reports First Quarter Fiscal 2017 Results

Exhibit 99.1 Span-America Reports First Quarter Fiscal 2017 Results GREENVILLE, S.C.-(BUSINESS WIRE)-February 2, 2017-Span-America Medical Systems, Inc. (NASDAQ:SPAN) today reported its results for the first quarter ended December 31, 2016. Net income for the first quarter of fiscal 2017 declined 16% to $963,000, or $0.35 per diluted share, compared with $1.1 million, or $0.42 per diluted share, i

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 6, 2017 SPAN-AMERICA MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) South Carolina 0-11392 57-0525804 (State or other jurisdiction of incorporatio

Span-America Expects to Receive Insurance Proceeds Following Death of Company Founder and Former CEO, Donald C. Spann

Exhibit 99.1 Span-America Expects to Receive Insurance Proceeds Following Death of Company Founder and Former CEO, Donald C. Spann GREENVILLE, S.C.-(BUSINESS WIRE)-February 2, 2017-Span-America Medical Systems, Inc. (NASDAQ: SPAN) announced today that the company?s founder and former Chief Executive Officer, Donald C. Spann, passed away on January 6, 2017. He was age 82. As previously reported, th

SPAN / Span-America Medical Systems, Inc. / WELLS FARGO & COMPANY/MN Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1) SPAN AMER MED SYS INC (Name of Issuer) COM (Title of Class of Securities) 846396109 (CUSIP Number) December 31, 2016 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is

Span-America Medical Systems FORM DEF 14A

span20170120def14a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant [X] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(

Span-America Medical Systems FORM 10-K (Annual Report)

10-K 1 span2016082410k.htm FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K [X] Annual report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended October 1, 2016 or [ ] Transition report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to . Commission file nu

CONFIRMATION OF AMENDMENT NO. 1 TO LICENSE AND DISTIBUTION AGREEMENT

ex10-173.htm Exhibit 10.17.3 CONFIRMATION OF AMENDMENT NO. 1 TO LICENSE AND DISTIBUTION AGREEMENT The undersigned Trividia Manufacturing Solutions, Inc. F/K/A Nipro Consumer Healthcare, Inc. and d/b/a P.J. Noyes Company, a New Hampshire corporation with its principal offices located at 89 Bridge Street, Lancaster, New Hampshire 03584 (“Licensor”), hereby represents, warrants and confirms to Span-A

THOMPSON CONTRACT SUPPLY COMPANY LIMITED (hereinafter the "Landlord") - and - SPAN MEDICAL PRODUCTS CANADA INC. (hereinafter the "Tenant")

EX-10.15.2 2 ex10-152.htm EXHIBIT 10.15.2 Exhibit 10.15.2 THIS LEASE AMENDMENT AND EXTENSION made effective 4th day of November, 2016 between: THOMPSON CONTRACT SUPPLY COMPANY LIMITED (hereinafter the "Landlord") - and - SPAN MEDICAL PRODUCTS CANADA INC. (hereinafter the "Tenant") WHEREAS: (A) By a Lease dated December 9, 2011, the Landlord leased to the Tenant the premises municipally known as 46

Subsidiaries

ex21-1.htm Exhibit 21.1 Subsidiaries Span Medical Products Canada Inc. (“Span-Canada”) is a British Columbia corporation and a wholly-owned subsidiary of Span-America Medical Systems, Inc. Span-Canada operates under the registered business name M.C. Healthcare Products.

Span-America Reports Fourth Quarter and Fiscal Year 2016 Results

Exhibit 99.1 Span-America Reports Fourth Quarter and Fiscal Year 2016 Results GREENVILLE, S.C.-(BUSINESS WIRE)-November 14, 2016-Span-America Medical Systems, Inc. (NASDAQ:SPAN) today reported its results for the fourth quarter and fiscal year ended October 1, 2016. Net income for the fourth quarter of fiscal 2016 rose 10% to $1.4 million, or $0.51 per diluted share, compared with $1.3 million, or

Span-America Medical Systems SPAN-AMERICA MEDICAL SYSTEMS, INC. 8-K (Current Report/Significant Event)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 14, 2016 SPAN-AMERICA MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) South Carolina 0-11392 57-0525804 (State or other jurisdiction of incorporat

Span-America Medical Systems FORM 10-Q (Quarterly Report)

10-Q 1 span2016063010q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q X QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended July 2, 2016 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From to Commission File Numbe

Span-America Medical Systems FORM 10-Q (Quarterly Report)

10-Q 1 span2016063010q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q X QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended July 2, 2016 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From to Commission File Numbe

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 4, 2016 SPAN-AMERICA MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) South Carolina 0-11392 57-0525804 (State or other jurisdiction of incorporation

Span-America Reports Third Quarter Fiscal 2016 Results Earnings Per Share Up 6% to $0.34 Per Diluted Share

Exhibit 99.1 Span-America Reports Third Quarter Fiscal 2016 Results Earnings Per Share Up 6% to $0.34 Per Diluted Share GREENVILLE, S.C.-(BUSINESS WIRE)-August 4, 2016-Span-America Medical Systems, Inc. (NASDAQ: SPAN) today reported its results for the third fiscal quarter ended July 2, 2016. Earnings per diluted share rose 6% to $0.34 in the third quarter of fiscal 2016 compared with $0.32 in the

Span-America Medical Systems FORM 10-Q (Quarterly Report)

span2016033110q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q X QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended April 2, 2016 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From to Commission File Number 0-11392 SPAN-A

Span-America Reports Second Quarter 2016 Results Earnings Per Share Up 8% to $0.28 Per Diluted Share

EX-99.1 2 a51336450ex991.htm EXHIBIT 99.1 Exhibit 99.1 Span-America Reports Second Quarter 2016 Results Earnings Per Share Up 8% to $0.28 Per Diluted Share GREENVILLE, S.C.-(BUSINESS WIRE)-May 5, 2016-Span-America Medical Systems, Inc. (NASDAQ:SPAN) today reported its results for the second fiscal quarter ended April 2, 2016. Net income per diluted share rose 8% to $0.28 in the second quarter of f

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 5, 2016 SPAN-AMERICA MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) South Carolina 0-11392 57-0525804 (State or other jurisdiction of incorporation) (

Span-America Medical Systems FORM 8-K (Current Report/Significant Event)

span201602088k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 25, 2016 SPAN-AMERICA MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) South Carolina 0-11392 57-0525804 (State or other jurisdi

SPAN / Span-America Medical Systems, Inc. 10-Q - Quarterly Report - FORM 10-Q

10-Q 1 span2016021310q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q X QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended January 2, 2016 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From to Commission File Nu

AMENDMENT NO. 1 TO LICENSE AND DISTIBUTION AGREEMENT

span201602088k.htm Exhibit 10.1 AMENDMENT NO. 1 TO LICENSE AND DISTIBUTION AGREEMENT THIS AMENDMENT NO. 1 (“Amendment”), effective this 1st day of February, 2016 (the “Amendment Effective Date”), is entered into by and between NIPRO CONSUMER HEALTHCARE, INC., d/b/a P.J. NOYES COMPANY, a New Hampshire corporation, with its principal offices located at 89 Bridge Street, Lancaster, New Hampshire 0358

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

span201602088k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 2, 2016 SPAN-AMERICA MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) South Carolina 0-11392 57-0525804 (State or other jurisdic

Financial Statements and Exhibits, Results of Operations and Financial Condition

8-K 1 a51273662.htm SPAN-AMERICA MEDICAL SYSTEMS, INC. 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 4, 2016 SPAN-AMERICA MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) South Carolina 0-1

Span-America Reports Improved First Quarter 2016 Results Sales Up 36% to $21.5 Million Earnings Per Share Up 28% to $0.42 Per Diluted Share

EX-99.1 2 a51273662ex991.htm EXHIBIT 99.1 Exhibit 99.1 Span-America Reports Improved First Quarter 2016 Results Sales Up 36% to $21.5 Million Earnings Per Share Up 28% to $0.42 Per Diluted Share GREENVILLE, S.C.-(BUSINESS WIRE)-February 4, 2016-Span-America Medical Systems, Inc. (NASDAQ:SPAN) today reported growth in sales and net income for the first quarter ended January 2, 2016. Net income for

SPAN / Span-America Medical Systems, Inc. / WELLS FARGO & COMPANY/MN Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. ) SPAN AMER MED SYS INC (Name of Issuer) COM (Title of Class of Securities) 846396109 (CUSIP Number) December 31, 2015 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is

Span-America Medical Systems FORM DEF 14A

span20160124def14a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant [X] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(

Exhibit 21.1

ex21-1.htm Exhibit 21.1 Subsidiaries Span Medical Products Canada Inc. (“Span-Canada”) is a British Columbia corporation and a wholly-owned subsidiary of Span-America Medical Systems, Inc. Span-Canada operates under the registered business name M.C. Healthcare Products.

SPAN / Span-America Medical Systems, Inc. 10-K - Annual Report - FORM 10-K

span20150930b10k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K [X] Annual report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended October 3, 2015 or [ ] Transition report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to . Commission file number 0-11392 SPA

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 9, 2015 SPAN-AMERICA MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) South Carolina 0-11392 57-0525804 (State or other jurisdiction of incorporati

Span-America Reports Improved Fourth Quarter and Fiscal Year 2015 Results Fourth Quarter Sales Up 36% to $17.7 Million Net Income Jumps 96% to $1.3 Million, or $0.43 Per Diluted Share

Exhibit 99.1 Span-America Reports Improved Fourth Quarter and Fiscal Year 2015 Results Fourth Quarter Sales Up 36% to $17.7 Million Net Income Jumps 96% to $1.3 Million, or $0.43 Per Diluted Share GREENVILLE, S.C.-(BUSINESS WIRE)-November 9, 2015-Span-America Medical Systems, Inc. (NASDAQ:SPAN) today reported growth in sales and net income for the fourth quarter and fiscal year ended October 3, 20

SPAN / Span-America Medical Systems, Inc. / Zucker Anita G Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* Span-America Medical Systems, Inc. - (Name of Issuer) Common Stock - (Title of Class of Securities) 846396109 - (CUSIP Number) Anita G. Zucker, as Trustee of Jerry Zucker Revocable Trust c/o The Inter Tech Group, Inc. 4838 Jenkins Avenue North Charleston

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Financial Statements and Exhibits

8-K 1 span201510018k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 28, 2015 SPAN-AMERICA MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) South Carolina 0-11392 57-0525804 (State

SPAN-AMERICA REPURCHASES 261,310 SHARES FROM FORMER DIRECTOR ROBERT B. JOHNSTON AND THE JERRY ZUCKER REVOCABLE TRUST

EX-99.1 4 ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Contact: Jim Ferguson President and Chief Executive Officer (864) 288-8877, ext. 6912 SPAN-AMERICA REPURCHASES 261,310 SHARES FROM FORMER DIRECTOR ROBERT B. JOHNSTON AND THE JERRY ZUCKER REVOCABLE TRUST GREENVILLE, S.C. (October 2, 2015) – Span-America Medical Systems, Inc. (NASDAQ:SPAN) announced today that it has repurchased 261,310 shares of its co

STOCK PURCHASE AGREEMENT

EX-10.1 3 ex10-1.htm EXHIBIT 10.1 Exhibit 10.1 STOCK PURCHASE AGREEMENT This Stock Purchase Agreement (the “Agreement”) is entered into as of September 28, 2015 by and between Span-America Medical Systems, Inc., a South Carolina corporation (“Buyer”), and Anita G. Zucker, as Trustee of The Jerry Zucker Revocable Trust dated March 20, 2007 and as successor-in-interest to Jerry Zucker, deceased (the

AMENDED & RESTATED STANDSTILL AGREEMENT

EX-4.1 2 ex4-1.htm EXHIBIT 4.1 Exhibit 4.1 AMENDED & RESTATED STANDSTILL AGREEMENT This Amended & Restated Standstill Agreement (this “Agreement”) is made and entered into as of September 28, 2015 between Span-America Medical Systems, Inc., a South Carolina corporation (the “Company”), Anita G. Zucker, as Trustee of The Jerry Zucker Revocable Trust dated March 20, 2007 and as successor-in-interest

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 5, 2015 SPAN-AMERICA MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) South Carolina 0-11392 57-0525804 (State or other jurisdiction of incorporation

Span-America Reports Improved Third Quarter 2015 Results Sales Up 19% to $15.8 Million Net Income Jumps 155% to $0.32 Per Diluted Share

Exhibit 99.1 Span-America Reports Improved Third Quarter 2015 Results Sales Up 19% to $15.8 Million Net Income Jumps 155% to $0.32 Per Diluted Share GREENVILLE, S.C.-(BUSINESS WIRE)-August 5, 2015-Span-America Medical Systems, Inc. (NASDAQ:SPAN) today reported improved results for the third fiscal quarter and nine months ended June 27, 2015 compared with the same periods in fiscal 2014. Net sales

Span-America Medical Systems SPAN-AMERICA MEDICAL SYSTEMS, INC. 8-K (Current Report/Significant Event)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 9, 2015 SPAN-AMERICA MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) South Carolina 0-11392 57-0525804 (State or other jurisdiction of incorporation)

Span-America’s Consumer Bedding Products Selected for Major Retailer’s Seasonal Promotion

Exhibit 99.1 Span-America’s Consumer Bedding Products Selected for Major Retailer’s Seasonal Promotion GREENVILLE, S.C.-(BUSINESS WIRE)-June 9, 2015-Span-America Medical Systems, Inc. (NASDAQ:SPAN) announced that it was notified by a major retail customer that the Company has been selected as a supplier of consumer bedding products for the retailer’s seasonal promotion in the fall of 2015. The Com

Financial Statements and Exhibits

8-K 1 span201505288k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 27, 2015 SPAN-AMERICA MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) South Carolina 0-11392 57-0525804 (State or oth

FIRST AMENDMENT TO LOAN DOCUMENTS

ex10-1.htm Exhibit 10.1 FIRST AMENDMENT TO LOAN DOCUMENTS THIS FIRST AMENDMENT TO LOAN DOCUMENTS (the ?Amendment?) is executed to be effective as of the 27th day of May, 2015, by and between TD Bank, N.A., a National Association (together with its successors and assigns, the ?Lender?); Span-America Medical Systems, Inc., a South Carolina corporation (the ?Borrower?) and Span Medical Products Canad

Span-America Medical Systems FORM 8-K (Current Report/Significant Event)

span201505058k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 30, 2015 SPAN-AMERICA MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) South Carolina 0-11392 57-0525804 (State or other jurisdicti

EX-10.1

EX-10.1 2 ex10-1.htm EXHIBIT 10.1 Exhibit 10.1

Span-America Reports Second Quarter 2015 Results

EX-99.1 2 a51093002ex991.htm EXHIBIT 99.1 Exhibit 99.1 Span-America Reports Second Quarter 2015 Results GREENVILLE, S.C.-(BUSINESS WIRE)-April 30, 2015-Span-America Medical Systems, Inc. (NASDAQ:SPAN) today reported results for the second fiscal quarter ended March 28, 2015. Net sales for the second quarter of fiscal 2015 were up 2% to $15.0 million compared with $14.7 million in the second quarte

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 30, 2015 SPAN-AMERICA MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) South Carolina 0-11392 57-0525804 (State or other jurisdiction of incorporation

Submission of Matters to a Vote of Security Holders

span201502238k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 19, 2015 SPAN-AMERICA MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) South Carolina 0-11392 57-0525804 (State or other jurisdi

SPAN / Span-America Medical Systems, Inc. 144 - - FORM 144

henrion20150210144.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933 ATTENTION: Transmit for filing 3 copies of this form concurrently with either placing an order with a broker to execute sale or executing a sale directly with a market maker 1 (a) NAME OF ISSUER (Please t

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 3, 2015 SPAN-AMERICA MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) South Carolina 0-11392 57-0525804 (State or other jurisdiction of incorporati

Span-America Reports Improved First Quarter 2015 Results

Exhibit 99.1 Span-America Reports Improved First Quarter 2015 Results GREENVILLE, S.C.-(BUSINESS WIRE)-February 3, 2015-Span-America Medical Systems, Inc. (NASDAQ:SPAN) today reported improved results for the first fiscal quarter ended January 3, 2015. Net income for the first quarter of fiscal 2015 rose 46% to $970,000, or $0.32 per diluted share, compared with $666,000, or $0.22 per diluted shar

SPAN / Span-America Medical Systems, Inc. DEF 14A - - FORM DEF 14A

DEF 14A 1 span20150121def14a.htm FORM DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant [X] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only (as p

SPAN-AMERICA MEDICAL SYSTEMS, INC. RESOLUTIONS OF THE BOARD OF DIRECTORS AMENDING THE AMENDED & RESTATED BYLAWS November 12, 2014

Exhibit 3.2.3 SPAN-AMERICA MEDICAL SYSTEMS, INC. RESOLUTIONS OF THE BOARD OF DIRECTORS AMENDING THE AMENDED & RESTATED BYLAWS November 12, 2014 The board of directors (the “Board”) of Span-America Medical Systems, Inc., a South Carolina corporation (the “Company”) hereby adopts the following resolutions at a meeting duly called and held on the date set forth above: WHEREAS, the Board has determine

Span-America to Nominate Thomas J. Sullivan to Board of Directors

Exhibit 99.1 Span-America to Nominate Thomas J. Sullivan to Board of Directors GREENVILLE, S.C.-(BUSINESS WIRE)-November 18, 2014-Span-America Medical Systems, Inc. (NASDAQ: SPAN) announced that Thomas J. Sullivan will be nominated for election to the Board of Directors at the Company’s next annual meeting, which is expected to be held in February, 2015. Mr. Sullivan currently serves as President,

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 12, 2014 SPAN-AMERICA MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) South Carolina 0-11392 57-0525804 (State or other jurisdiction of incorporat

Span-America Declares Special Cash Dividend of $1.00 Per Share and Regular Quarterly Dividend of $0.15 Per Share Marks 100th Consecutive Quarterly Dividend Payment

Exhibit 99.1 Span-America Declares Special Cash Dividend of $1.00 Per Share and Regular Quarterly Dividend of $0.15 Per Share Marks 100th Consecutive Quarterly Dividend Payment GREENVILLE, S.C.-(BUSINESS WIRE)-November 14, 2014-Span-America Medical Systems, Inc. (NASDAQ: SPAN) announced today that the Board of Directors declared a special cash dividend of $1.00 per share. The special dividend is p

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 14, 2014 SPAN-AMERICA MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) South Carolina 0-11392 57-0525804 (State or other jurisdiction of incorporat

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 6, 2014 SPAN-AMERICA MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) South Carolina 0-11392 57-0525804 (State or other jurisdiction of incorporati

Span-America Reports Fourth Quarter and Fiscal Year 2014 Results

Exhibit 99.1 Span-America Reports Fourth Quarter and Fiscal Year 2014 Results GREENVILLE, S.C.-(BUSINESS WIRE)-November 6, 2014-Span-America Medical Systems, Inc. (NASDAQ:SPAN) today reported its results for the fourth quarter and fiscal year ended September 27, 2014. Net income for the fourth quarter of fiscal 2014 was $656,000, or $0.22 per diluted share, compared with $1.2 million, or $0.42 per

Span-America Reports Third Quarter 2014 Results Announces New Consumer Bedding Business with Major Retailer

EX-99.1 2 a50918269ex991.htm EXHIBIT 99.1 Exhibit 99.1 Span-America Reports Third Quarter 2014 Results Announces New Consumer Bedding Business with Major Retailer GREENVILLE, S.C.-(BUSINESS WIRE)-August 4, 2014-Span-America Medical Systems, Inc. (NASDAQ:SPAN) today reported its results for the third fiscal quarter ended June 28, 2014. Net income for the third quarter of fiscal 2014 was $378,000, o

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 4, 2014 SPAN-AMERICA MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) South Carolina 0-11392 57-0525804 (State or other jurisdiction of incorporation

Span-America Reports Second Quarter 2014 Results

Exhibit 99.1 Span-America Reports Second Quarter 2014 Results GREENVILLE, S.C.-(BUSINESS WIRE)-May 1, 2014-Span-America Medical Systems, Inc. (NASDAQ:SPAN) today reported its results for the second fiscal quarter ended March 29, 2014. Net income for the second quarter of fiscal 2014 was $891,000, or $0.30 per diluted share, compared with $1.2 million, or $0.41 per diluted share, in the second quar

Financial Statements and Exhibits, Results of Operations and Financial Condition - SPAN-AMERICA MEDICAL SYSTEMS, INC. 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 1, 2014 SPAN-AMERICA MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) South Carolina 0-11392 57-0525804 (State or other jurisdiction of incorporation) (

Submission of Matters to a Vote of Security Holders

span201402248k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 20, 2014 SPAN-AMERICA MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) South Carolina 0-11392 57-0525804 (State or other jurisdi

Span-America Medical Systems FORM 10-Q (Quarterly Report)

span2013123110q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q X QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended December 28, 2013 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From to Commission File Number 0-11392 SP

Span-America Reports First Quarter 2014 Results

Exhibit 99.1 Span-America Reports First Quarter 2014 Results GREENVILLE, S.C.-(BUSINESS WIRE)-January 29, 2014-Span-America Medical Systems, Inc. (NASDAQ:SPAN) today reported its results for the first fiscal quarter ended December 28, 2013. Net income for the first quarter of fiscal 2014 was $666,000, or $0.22 per diluted share, compared with $1.4 million, or $0.46 per diluted share, in the first

Financial Statements and Exhibits, Results of Operations and Financial Condition - SPAN-AMERICA MEDICAL SYSTEMS, INC. 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 29, 2014 SPAN-AMERICA MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) South Carolina 0-11392 57-0525804 (State or other jurisdiction of incorporati

- FORM DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant [X] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) [X] Definitive P

Span-America Reports Fourth Quarter and Fiscal Year 2013 Results

Exhibit 99.1 Span-America Reports Fourth Quarter and Fiscal Year 2013 Results GREENVILLE, S.C.-(BUSINESS WIRE)-November 6, 2013-Span-America Medical Systems, Inc. (NASDAQ:SPAN) today reported its results for the fourth quarter and fiscal year ended September 28, 2013. Net sales for the fourth quarter of fiscal 2013 decreased by 5% to $16.9 million compared with $17.8 million in the fourth quarter

Financial Statements and Exhibits, Results of Operations and Financial Condition - SPAN-AMERICA MEDICAL SYSTEMS, INC. 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 6, 2013 SPAN-AMERICA MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) South Carolina 0-11392 57-0525804 (State or other jurisdiction of incorporati

- FORM 144

henrion20130814144.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933 ATTENTION: Transmit for filing 3 copies of this form concurrently with either placing an order with a broker to execute sale or executing a sale directly with a market maker 1 (a) NAME OF ISSUER (Please t

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 31, 2013 SPAN-AMERICA MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) South Carolina 0-11392 57-0525804 (State or other jurisdiction of incorporation)

Span-America Reports Third Quarter Results for Fiscal 2013 Third Quarter Net Income Jumps 64% on Growth in Medical Segment Sales

Exhibit 99.1 Span-America Reports Third Quarter Results for Fiscal 2013 Third Quarter Net Income Jumps 64% on Growth in Medical Segment Sales GREENVILLE, S.C.-(BUSINESS WIRE)-July 31, 2013-Span-America Medical Systems, Inc. (NASDAQ:SPAN) today reported higher sales and net income for the third fiscal quarter ended June 29, 2013. Net income for the third quarter of fiscal 2013 increased 64% to $1.2

[Signatures continue on next page]

Exhibit 10.1 May 23, 2013 Span-America Medical Systems, Inc. 70 Commerce Center Greenville, SC 29615 Attention: Jim Ferguson, President & CEO RE: Assignment & Assumption of Distribution Agreement dated March 1, 1999 as amended by Addendum dated January 1, 2002 (collectively, the “Distribution Agreement”) by and between Span-America Medical Systems, Inc. (“Span-America”) and Louisville Bedding Comp

Entry into a Material Definitive Agreement, Financial Statements and Exhibits - FORM 8-K

span201305288k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 24, 2013 SPAN-AMERICA MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) South Carolina 0-11392 57-0525804 (State or other jurisdiction

Span-America Reports Second Quarter Results for Fiscal 2013

Exhibit 99.1 Span-America Reports Second Quarter Results for Fiscal 2013 GREENVILLE, S.C.-(BUSINESS WIRE)-May 1, 2013-Span-America Medical Systems, Inc. (NASDAQ:SPAN) today reported results for its second fiscal quarter and six months ended March 30, 2013. Net income for the second quarter of fiscal 2013 was $1.2 million, or $0.41 per diluted share, compared with $1.8 million, or $0.62 per diluted

Financial Statements and Exhibits, Results of Operations and Financial Condition - SPAN-AMERICA MEDICAL SYSTEMS, INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 1, 2013 SPAN-AMERICA MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) South Carolina 0-11392 57-0525804 (State or other jurisdiction of incorporation) (

Material Modification to Rights of Security Holders

8-K 1 span201303258k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 24, 2013 SPAN-AMERICA MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) South Carolina 0-11392 57-0525804 (State or o

STANDSTILL AGREEMENT

Exhibit 4.1 STANDSTILL AGREEMENT This Standstill Agreement (this “Agreement”) is made and entered into as of March 1, 2013 between Span-America Medical Systems, Inc., a South Carolina corporation (the “Company”), Anita G. Zucker, as Trustee of The Jerry Zucker Revocable Trust dated March 20, 2007 and as successor-in-interest to Jerry Zucker, deceased (the “Zucker Trustee”), Robert B. Johnston, a n

Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits - FORM 8-K

span201303058k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 1, 2013 SPAN-AMERICA MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) South Carolina 0-11392 57-0525804 (State or other jurisdictio

Submission of Matters to a Vote of Security Holders

span201302288k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 21, 2013 SPAN-AMERICA MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) South Carolina 0-11392 57-0525804 (State or other jurisdi

Span-America Reports Higher First Quarter Sales and Net Income Net Income Rises 21% to $1.4 Million

Exhibit 99.1 Span-America Reports Higher First Quarter Sales and Net Income Net Income Rises 21% to $1.4 Million GREENVILLE, S.C.-(BUSINESS WIRE)-January 31, 2013-Span-America Medical Systems, Inc. (NASDAQ:SPAN) today reported higher sales and net income for the first quarter ended December 29, 2012. Net income for the first quarter of fiscal 2013 rose 21% to $1.4 million, or $0.46 per diluted sha

Results of Operations and Financial Condition, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 31, 2013 SPAN-AMERICA MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) South Carolina 0-11392 57-0525804 (State or other jurisdiction of incorporati

- DEFINITIVE SCHEDULE 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant [X] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) [X] Definitive P

- POST-EFFECTIVE AMENDMENT NO.2

As filed with the Securities and Exchange Commission on December 21, 2012. Registration File No. 33-84374 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Post-Effective Amendment No. 2 to FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SPAN-AMERICA MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) South Carolina 57-0525804 (State

- POST-EFFECTIVE AMENDMENT NO. 1

As filed with the Securities and Exchange Commission on December 21, 2012. Registration File No. 33-32896 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Post-Effective Amendment No. 1 to FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SPAN-AMERICA MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) South Carolina 57-0525804 (State

- FORM 144

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933 ATTENTION: Transmit for filing 3 copies of this form concurrently with either placing an order with a broker to execute sale or executing a sale directly with a market maker 1 (a) NAME OF ISSUER (Please type or print) (b) IRS I

Financial Statements and Exhibits, Results of Operations and Financial Condition - SPAN-AMERICA MEDICAL SYSTEMS, INC. 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 8, 2012 SPAN-AMERICA MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) South Carolina 0-11392 57-0525804 (State or other jurisdiction of incorporati

Span-America Reports Growth in Sales and Net Income for Fourth Quarter and Fiscal Year 2012

Exhibit 99.1 Span-America Reports Growth in Sales and Net Income for Fourth Quarter and Fiscal Year 2012 GREENVILLE, S.C.-(BUSINESS WIRE)-November 8, 2012-Span-America Medical Systems, Inc. (NASDAQ:SPAN) today reported growth in sales and net income for the fourth quarter and fiscal year ended September 29, 2012. The company reported that fourth quarter sales rose 30% to $17.8 million, and net inc

Span-America Declares Special Cash Dividend of $1.00 Per Share and Declares Regular Quarterly Dividend of $0.125 Per Share

Exhibit 99.1 Span-America Declares Special Cash Dividend of $1.00 Per Share and Declares Regular Quarterly Dividend of $0.125 Per Share GREENVILLE, S.C.-(BUSINESS WIRE)-November 8, 2012-Span-America Medical Systems, Inc. (NASDAQ: SPAN) announced today that the Board of Directors declared a special cash dividend of $1.00 per share. The Board of Directors also declared a regular quarterly cash divid

Regulation FD Disclosure, Financial Statements and Exhibits - SPAN-AMERICA MEDICAL SYSTEMS, INC. 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 8, 2012 SPAN-AMERICA MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) South Carolina 0-11392 57-0525804 (State or other jurisdiction of incorporati

Financial Statements and Exhibits, Results of Operations and Financial Condition - SPAN-AMERICA MEDICAL SYSTEMS, INC. 8K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 2, 2012 SPAN-AMERICA MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) South Carolina 0-11392 57-0525804 (State or other jurisdiction of incorporation

Span-America Reports Growth in Sales for Third Quarter of Fiscal 2012 Net Income Up 32% to $3.7 Million for First Nine Months

Exhibit 99.1 Span-America Reports Growth in Sales for Third Quarter of Fiscal 2012 Net Income Up 32% to $3.7 Million for First Nine Months GREENVILLE, S.C.-(BUSINESS WIRE)-August 2, 2012-Span-America Medical Systems, Inc. (NASDAQ:SPAN) today reported growth in sales for the third fiscal quarter and nine months ended June 30, 2012. Net sales for the third quarter of fiscal 2012 increased 24% to $16

SPAN / Span-America Medical Systems, Inc. / Zucker Anita G Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* Span-America Medical Systems, Inc. - (Name of Issuer) Common Stock - (Title of Class of Securities) 846396109 - (CUSIP Number) Anita G. Zucker, as Trustee of Jerry Zucker Revocable Trust c/o The Inter Tech Group, Inc. 4838 Jenkins Avenue North Charleston

- FORM 144

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933 ATTENTION: Transmit for filing 3 copies of this form concurrently with either placing an order with a broker to execute sale or executing a sale directly with a market maker 1 (a) NAME OF ISSUER (Please type or print) (b) IRS I

Financial Statements and Exhibits, Results of Operations and Financial Condition - SPAN-AMERICA MEDICAL SYSTEMS, INC. 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 7, 2012 SPAN-AMERICA MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) South Carolina 0-11392 57-0525804 (State or other jurisdiction of incorporation) (

Span-America Reports Growth in Sales and Net Income for Second Quarter of Fiscal 2012 Sales Jump 56% - Net Income Increases 74%

Exhibit 99.1 Span-America Reports Growth in Sales and Net Income for Second Quarter of Fiscal 2012 Sales Jump 56% - Net Income Increases 74% GREENVILLE, S.C.-(BUSINESS WIRE)-May 7, 2012-Span-America Medical Systems, Inc. (NASDAQ:SPAN) today reported strong growth in sales and net income for the second fiscal quarter and six months ended March 31, 2012. Net income for the second quarter of fiscal 2

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits - FORM 8-K/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A AMENDMENT NO. 1 TO CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 24, 2012 (December 9, 2011) SPAN-AMERICA MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) South Carolina 0-11392 57-0525804 (S

M.C. HEALTHCARE PRODUCTS INC. REPORT ON FINANCIAL STATEMENTS FOR THE YEAR ENDED JULY 31, 2011

Exhibit 99.1 M.C. HEALTHCARE PRODUCTS INC. REPORT ON FINANCIAL STATEMENTS FOR THE YEAR ENDED JULY 31, 2011 M.C. HEALTHCARE PRODUCTS INC. TABLE OF CONTENTS Page INDEPENDENT AUDITOR’S REPORT 1 FINANCIAL STATEMENTS Balance sheet 2 Statement of income and retained earnings 3 Statement of cash flows 4 NOTES TO FINANCIAL STATEMENTS 5-10 INDEPENDENT AUDITOR’S REPORT The Stockholder M.C. Healthcare Produc

Unaudited Pro Forma Combined Condensed Statement of Earnings (In U.S. Dollars) Span-America MCHP Historical Historical October 1, July 31, Pro Forma Span-America 2011 2011 Adjustments Pro Forma Net sales $ 52,578,372 $ 12,309,151 $ - $ 64,887,523 Cos

Exhibit 99.2 Unaudited Pro Forma Combined Condensed Statement of Earnings (In U.S. Dollars) Span-America MCHP Historical Historical October 1, July 31, Pro Forma Span-America 2011 2011 Adjustments Pro Forma Net sales $ 52,578,372 $ 12,309,151 $ - $ 64,887,523 Cost of goods sold 34,433,918 8,190,298 85,553 A 42,685,813 (23,956 ) B Gross profit 18,144,454 4,118,853 (61,597 ) 22,201,710 Selling, gene

Submission of Matters to a Vote of Security Holders - FORM 8-K

span201202218k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 16, 2012 SPAN-AMERICA MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) South Carolina 0-11392 57-0525804 (State or other jurisdi

-

February 14, 2012 VIA EMAIL and FEDEX Ms. Lynn Dicker Mr. Kevin L. Vaughn Division of Corporate Finance U.S. Securities & Exchange Commission 100 F Street, NE Washington, D.C. 20549 Re: Span-America Medical Systems, Inc. Form 10-K for the Fiscal Year Ended October 1, 2011 Filed December 30, 2011 File No. 000-11392 Dear Ms. Dicker and Mr. Vaughn: Thank you for your comment letter dated January 31,

Financial Statements and Exhibits, Results of Operations and Financial Condition - SPAN-AMERICA MEDICAL SYSTEMS, INC. 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 2, 2012 SPAN-AMERICA MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) South Carolina 0-11392 57-0525804 (State or other jurisdiction of incorporati

Span-America Reports Strong First Quarter Results Sales Jump 75% to $20.5 Million – Net Income Up 57% to $1.1 Million

Exhibit 99.1 Span-America Reports Strong First Quarter Results Sales Jump 75% to $20.5 Million – Net Income Up 57% to $1.1 Million GREENVILLE, S.C.-(BUSINESS WIRE)-February 2, 2012-Span-America Medical Systems, Inc. (NASDAQ:SPAN) today reported record sales and strong growth in net income for the first quarter ended December 31, 2011. Net income for the first quarter of fiscal 2012 rose 57% to $1.

- FORM DEF 14A

DEF 14A 1 spandef14a-011612.htm FORM DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant [X] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only (as pe